Paragon Care Limited · ASX:PGC
Paragon Care — FY2020 Earnings Presentation
21 slides from Paragon Care's earnings presentation, Aug 31, 2020
Slide 1: Full Year Results Presentation 2020
ParagonCare Health. Covered. FULL YEAR RES PRESENTATION 2020
Slide 2: New management and strategic review outcomes
2 ▪ New Chief Executive Officer: Phil Nicholl appointed An expansive review of operations and strategy that Focused on sustainable growth initiatives: CEO in November 2019 (CEO of acquired device delivered the following: ▪ Cost structures reduced in line with business business) ▪ Simplified business
Slide 3: Paragon Care Limited (ASX:PGC)
3 Paragon Care Limited (ASX:PGC) 3
Slide 4: Paragon Care Limited (ASX:PGC)
4 • • • • • 231.7 28.2 236.1 22.9 6.2 5.4 18.2 2.8 17.1 136.7 117.2 -21.2 Paragon Care Limited (ASX:PGC) 4
Slide 5: Revenue from continuing operations
5 Revenue from continuing operations for the Management replaced much of the Post the Strategic Review the scope of The Company quickly initiated cost year reached $231.7m (2019 $236m). elective surgery lost revenue with new the revised cost-out program was management strategies in response to incom
Slide 6: Paragon Care Limited (ASX:PGC)
6 Paragon Care Limited (ASX:PGC) 6
Slide 7: Paragon Care Limited (ASX:PGC)
7 Paragon Care Limited (ASX:PGC) 7
Slide 8: Strategic Review completed in FY20 under the new management team
8 The Company completed its Strategic Review in FY20 under the new • management team. • o The outcome of the review, along with the o impact of COVID-19, resulted in the o Company simplifying its strategy and o • closing many non-core projects initiated • over the last 18 months. • • o o o o • Parag
Slide 9: Paragon Care Limited (ASX:PGC)
9 Paragon Care Limited (ASX:PGC) 9
Slide 10: Assets and Liabilities
10 Assets • Trade debtors down from $46.0m in Dec-19 and $44.1m in Jun-19 to $31.6m after restructure of collections process • Inventory down from $53.6m in Dec-19 and $51.4m in Jun-19 to $46.7m as part of the product and warehouse rationalisation program • Non-current assets down from $258.9m in De
Slide 11: Operations, Investing and Financing activities
11 Operations • Improved debtor collections in 2HY20 has seen a $10m improvement in cash flow. • Income tax refunds received due to overpayments in prior years of $5m in FY20 Investing activities • Reduced capital expenditure in 2HY20 as projects were closed as part of the new simplification strateg
Slide 12: Paragon Care Limited (ASX:PGC)
12 Paragon Care Limited (ASX:PGC) 12
Slide 13: Significant restructure of business operations
13 In August 2020, the Company received approval A number of cost-out initiatives implemented: Meeting increasing demand for new products: from its bankers for an amendment to its banking facilities delivering: • Significant restructure of business operations • Sourcing of new products (devices & an
Slide 14: Paragon Care Limited (ASX:PGC)
14 Paragon Care Limited (ASX:PGC) 14
Slide 15: Paragon Care Limited (ASX:PGC)
15 7.1% 5.0% 4.0% 3.3% Paragon Care Limited (ASX:PGC) 15
Slide 16: Paragon Care Limited (ASX:PGC)
16 Paragon Care Limited (ASX:PGC) 16
Slide 17: Paragon Care Limited (ASX:PGC)
17 • • • • • • • • • • Paragon Care Limited (ASX:PGC) 17
Slide 18: Paragon Care Limited (ASX:PGC)
18 Paragon Care Limited (ASX:PGC) 18
Slide 19: Board of Directors
19 Non-Executive Chairman Non-Executive Director • Co-founder of Paragon Care • Over 35 years’ experience in the health sector • Extensive commercial and financial experience • Board positions with ASX-listed companies and for- • Chairman of Zenitas Healthcare, Rhythm Biosciences profit and not-for-
Slide 20: Summary information
20 Summary information This Presentation contains summary information about Paragon Care and its activities current as at 30 June 2020. The information in the Presentation is of a general nature and does not purport to be complete or comprise all information which a shareholder or potential investor
Slide 21: Paragon Care Limited (ASX:PGC)
21 Paragon Care Limited (ASX:PGC) 21